Investigating the impact of Glucagon-like peptide-1 therapy on total shoulder arthroplasty outcomes. Journal Abstract - Guideline Central

Investigating the impact of Glucagon-like peptide-1 therapy on total shoulder arthroplasty outcomes.

Published: 2026 Aug 20

Authors

, , , , , , , ,

Abstract

The increasing prevalence of Glucagon-like peptide-1 receptor agonists (GLP-1 RA) has raised concerns about their perioperative impact. Although database studies on GLP-1 RAs in total shoulder arthroplasty (TSA) have been published for diabetic and general TSA patients, results are conflicting, and the effects on patients across various obesity classes remain unexplored. This study aims to fill this gap.

Keywords: Diabetes, GLP-1 receptor agonist, Infection, Obesity, Orthopaedic surgery, Total shoulder arthroplasty

Source

International orthopaedics

Publication Type

Journal Article

Language

English

PubMed ID

42622874

You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.